To Evaluate Safety and Efficacy of EC-18 in COVID-19 Infection to Pneumonia
Not Applicable
Completed
- Conditions
- Certain infectious and parasitic diseases
- Registration Number
- KCT0005344
- Lead Sponsor
- Enzychem Lifesciences Corporation
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
1) Male or female =19 years old
2) Subjects with confirmed diagnoses of pneumonia caused by COVID-19 from:
• RT-PCR
• Chest x-ray or computed tomography (CT) scan (findings of the increased opacity on a chest X-ray, ground-glass opacity indicative of pneumonia on CT, opinion on consolidation, etc.)
Exclusion Criteria
1) Those who are diagnosed with viral pneumonia caused by other than COVID-19 or bacterial pneumonia during the screening
2) Patients with severe pneumonia according to the WHO guidance
• Have fever or signs of respiratory infections
• Satisfy any one of the following conditions: Respiratory rate > 30 breaths/min, severe respiratory distress, or room air oxygen saturation (SpO2) = 93%
Study & Design
- Study Type
- Interventional Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Probability of transfer of mild pneumonia patients to severe pneumonia or acute respiratory distress syndrome (ARDS)
- Secondary Outcome Measures
Name Time Method Patient's Questionnare (Self-symptom evaluation)